How many drugs treat Hyperkalemia?

Drug Landscape tracks 4 marketed treatments for Hyperkalemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hyperkalemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hyperkalemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyperkalemia (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hyperkalemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Phoslo	CALCIUM ACETATE	Fresenius Medcl Care	calcium acetate	1982-01-01
Calcium Gluceptate	calcium glucoheptonate	Abbott	calcium glucoheptonate	1972-01-01
Plegisol In Plastic Container	CALCIUM CHLORIDE	Pfizer	calcium chloride	1971-01-01
Sps	SODIUM POLYSTYRENE SULFONATE	Concordia	Potassium Binder [EPC]	1958-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Hyperkalemia
Abbott · 1 drug in Hyperkalemia
Concordia · 1 drug in Hyperkalemia
Fresenius Medcl Care · 1 drug in Hyperkalemia
Pfizer · 1 drug in Hyperkalemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hyperkalemia:

Cite this brief

Drug Landscape (2026). Hyperkalemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hyperkalemia. Accessed 2026-06-10.

Hyperkalemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing